InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Explore the detailed record of transactions filed by Jan HOFLACK, Director. Officer active across 2 companies, notably Oncodesign Precision Medicine S.A.. Aggregated, 2 filings have been recorded. Total volume traded: €5.3m. The latest transaction was disclosed on 8 December 2022 — Acquisition. Regulator: AMF. All data is accessible without signup.
Declarations2 total
€123,000150,000 shares@ €0.820.95% mcap100.0% of flow
ActionHors plateforme de négociation
2022DD876585·
Ideal exit: 4 Sept 2023 (T+270)
€5m357,840 shares@ €14.4239.78% mcap100.0% of flow
ActionHors plateforme de négociation
2022DD867440·
2 of 2 declarations
About Jan HOFLACK
Jan Hoflack is a Board Member of ONCODESIGN PRECISION MEDICINE S.A. and ONCODESIGN. He contributes to the governance of the companies and strategic decision-making, bringing his expertise in biotechnology and business development.
